A Study of Different Oral Thin Film (S)-Ketamine Formulations for Sublingual Administration in Healthy Participants

Brief Summary

The purpose of the study in healthy participants is to characterize the plasma pharmacokinetic (PK) profile of different single dose Oral Thin Film (OTF) (S)-ketamine formulations administered sublingually.

Intervention / Treatment

  • Drug: OTF 1
  • Drug: OTF 2
  • Drug: OTF 3
  • Drug: OTF 4

Condition or Disease

  • Healthy


Study Design

Study type: Interventional
Status: Recruiting
Study results: No Results Available
Age: 18 Years to 50 Years   (Adult)
Enrollment: 16 ()
Funded by: Industry


Clinical Trial Dates

Start date: Jun 19, 2020
Primary Completion: Aug 10, 2020
Completion Date: Aug 10, 2020
Study First Posted: Mar 09, 2020
Results First Posted: Aug 31, 2020
Last Updated: Jul 08, 2020

Sponsors / Collaborators

Lead Sponsor: N/A
Responsible Party: N/A


Eligibility Criteria

Sex: All
Minimum Age: 18
Maximum Age: 50

This clinical trial is recruiting

Are you interested in participating in this trial or others? We'd love to help.

More Details

NCT Number: NCT04300621
Other IDs: CR108774|2019-004428-39|54135419EDI1003
Study URL: https://ClinicalTrials.gov/show/NCT04300621
Last updated: Feb 22, 2021